Geron Corp (NASDAQ:GERN) - Share price - Overview

Stock Report

Geron Corp GERN

Last Price
$3.06

Day Change
0.01|0.33%

As of 22/05/2017
16:20:36 EDT | USD
Minimum 15 Minutes Delay.

Last Close3.05
Day Range2.98 - 3.07
Mkt Cap-
52-Wk Range1.81 - 3.15
Yield %-
ISINUS3741631036
Volume1,401,863
P/E-17.00
P/S81.30
P/CF-24.23

Share Price

Financials
201420152016
More ...
Income Statement
Revenue1.1536.376.16
Operating Income-36.31-0.56-30.65
Net Income-35.670.05-29.54
Basic EPS-0.230.00-0.19
Avg. Diluted Shares Outstanding154163159
Balance Sheet
Current Assets153.41115.89116.11
Non Current Assets19.1132.8714.14
Total Assets172.51148.76130.25
Current Liabilities41.806.637.87
Total Liabilities41.806.637.87
Total Equity130.71142.13122.38
Cash Flow
Operating Cash Flow9.35-24.20-18.37
Capital Expenditure-0.13-0.09-0.06
Free Cash Flow9.22-24.29-18.43

In millions, except "Basic EPS". Currency is USD.

Company Profile

Geron Corp is a biopharmaceutical company that supports the clinical stage development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies, by Janssen Biotech, Inc., or Janssen.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

18
Key Stats
More ...
Price/Earning TTM-16.94
Price/Book4.14
Price/Sales TTM78.81
Rev Growth (3 year avg)68.72
EPS Growth (3 year avg)-
Operating Margin % TTM-497.34
Net Margin % TTM-479.34
ROE TTM-22.33
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.